Private health insurers are systematically taking advantage of Medicare while denying care to seniors, a new report shows.
Health Care
Drugmakers are charging foreigners far lower prices for medicines they want shielded from new Medicare price cuts.
A pharmaceutical company could slow-walk research on medicines Americans need in response to Biden’s recently enacted federal price regulations.
As hundreds of thousands lose coverage and face major additional out-of-pocket expenses, private equity enters the spotlight.
As Medicaid redeterminations start up after a long COVID pause, little-known contractor Maximus stands to majorly benefit.
The U.S. health care system is broken and corrupt — our coverage shows we can fix it.
As Medicare becomes increasingly privatized, patients are speaking up about these for-profit insurers’ widespread practice of denying treatments they need.
Now that Biden and Congress have ended pandemic protections, nearly a million have lost Medicaid coverage for procedural reasons so far — and many more will.
Healthcare executives' pay topped $335 million last year while 100 million Americans were saddled with medical debt.
As Medicare privatization continues, insurers are milking massive profits from systematic overbilling and kneecapping modest Biden proposals to stop the scheme.